Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingtao Lu

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Journal of Pharmacology|December 13, 2024
Ferroportin inhibits the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via regulating ROS/PI3K/AKT signaling pathwayWeiting Shao, Fanxiao Liu, Lin Zhu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 9, 2008
p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidineXiaomin Deng, Jingtao Lu, Lois D Lehman-McKeeman, et al.
Plos One|July 2, 2026
Gold wrist-assisted PFNA reduces internal complications and enhances recovery in obese osteoporotic patients with intertrochanteric femur fracturesZhonghan Wu, Jianyang Li, Shitan Mao, et al.
Regulatory Toxicology and Pharmacology : RTP|November 8, 2015
Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbarylKathleen Brown, Martin Phillips, Christopher Grulke, et al.
Environmental Science & Technology|April 29, 2016
Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput AssaysJeremy A Leonard, Ashley Sobel Leonard, Daniel T Chang, et al.
Cancer Discovery|May 8, 2024
D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical ActivitiesJing Zhang, Sun Min Lim, Mi Ra Yu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 14, 2017
miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture ModelMerrie Mosedale, J Scott Eaddy, O Joseph Trask, et al.
Plos Computational Biology|February 13, 2016
Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model ConstructionJingtao Lu, Michael-Rock Goldsmith, Christopher M Grulke, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Journal of Pharmacology|December 13, 2024
Ferroportin inhibits the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via regulating ROS/PI3K/AKT signaling pathwayWeiting Shao, Fanxiao Liu, Lin Zhu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 9, 2008
p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidineXiaomin Deng, Jingtao Lu, Lois D Lehman-McKeeman, et al.
Plos One|July 2, 2026
Gold wrist-assisted PFNA reduces internal complications and enhances recovery in obese osteoporotic patients with intertrochanteric femur fracturesZhonghan Wu, Jianyang Li, Shitan Mao, et al.
Regulatory Toxicology and Pharmacology : RTP|November 8, 2015
Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbarylKathleen Brown, Martin Phillips, Christopher Grulke, et al.
Environmental Science & Technology|April 29, 2016
Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput AssaysJeremy A Leonard, Ashley Sobel Leonard, Daniel T Chang, et al.
Cancer Discovery|May 8, 2024
D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical ActivitiesJing Zhang, Sun Min Lim, Mi Ra Yu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 14, 2017
miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture ModelMerrie Mosedale, J Scott Eaddy, O Joseph Trask, et al.
Plos Computational Biology|February 13, 2016
Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model ConstructionJingtao Lu, Michael-Rock Goldsmith, Christopher M Grulke, et al.
Pageof 3